Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company RepliCel Life Sciences Inc.
DescriptionFibroblasts isolated from non-bulbar dermal sheath (NBDS) cells from a patient's hair follicles and replicated using RepliCel technology
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase I
Standard Indication Dermatology (unspecified)
Indication DetailsTreat aging skin; Treat UV-damaged skin
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today